Menu Search
Equities

Siemens Healthineers AG

SHLX:GER

Siemens Healthineers AG

Actions
Health CareMedical Equipment and Services
  • Price (EUR)49.55
  • Today's Change0.42 / 0.85%
  • Shares traded26.59k
  • 1 Year change-3.41%
  • Beta0.6416
Data delayed at least 15 minutes, as of Nov 22 2024 08:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy8
Outperform10
Hold4
Sell1
Strong Sell0

Share price forecast in EUR

The 22 analysts offering 12 month price targets for Siemens Healthineers AG have a median target of 59.50, with a high estimate of 66.00 and a low estimate of 50.00. The median estimate represents a 21.11% increase from the last price of 49.13.
High34.3%66.00
Med21.1%59.50
Low1.8%50.00

Dividends in EUR

Historical dividend information is not available for Siemens Healthineers AG.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

On Nov 06, 2024, Siemens Healthineers AG reported 4th quarter 2024 earnings of 0.67 per share. This result was in line with the consensus of the 7 analysts following the company and exceeded last year's 4th quarter results by 15.52%.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+5.03%
Siemens Healthineers AG reported annual 2024 earnings of 2.23 per share on Nov 06, 2024.
Average growth rate+14.10%
More ▼

Revenue history & estimates in EUR

Siemens Healthineers AG had 4th quarter 2024 revenues of 6.33bn. This bettered the 6.32bn consensus of the 7 analysts covering the company. This was 24.66% above the prior year's 4th quarter results.
Average growth rate+1.74%
Siemens Healthineers AG had revenues for the full year 2024 of 22.36bn. This was 3.15% above the prior year's results.
Average growth rate+12.03%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.